Figure 7
In vivo antitumor efficacy study (a) changes in tumor volume (b) changes in mice body weight (c) images of tumor sections. The antitumor study was carried out in QBC939 cells -bearing xenograft model and administered thrice at a fixed dose of 5 mg/kg. *p < 0.05, ***p < 0.001 is the statistical difference in the tumor volume between CSH-DTX and free DTX or CSH-DTX and control group.